Archives

by in
Entry Author Date Location
San Diego Life Sciences Roundup: Accelrys, AirStrip, Ligand, & More 10/25/12 San Diego
Xconomist of the Week: NPS’s Francois Nader Shares Lessons Learned 10/25/12 New York
Accelrys Adds Another Scientific Software Company to Its Portfolio 10/23/12 San Diego
San Diego Life Sciences Roundup: Optimer, Pfenex, OncoSec, & More 10/19/12 San Diego
Neurovance Raises $7 Million for ADHD Drug Development 10/19/12 Boston
NuMedii Sifts Data to Teach Old Drugs New Tricks 10/18/12 San Francisco
San Diego’s Cebix Names CEO, Raises $30.9M to Advance Diabetes Drug 10/17/12 San Diego
Kinsella Redux: Charting a Way Back for Life Sciences Startups 09/27/12 San Diego
Exelixis and Onyx Await Their Cancer-Drug Fates 09/18/12 San Francisco
EnVivo Forges Ahead With Alzheimer’s Drug 08/23/12 Boston
An Insider’s View on Raising Money from Life Sciences VCs 08/21/12 New York
MediciNova Raises Capital Through $20M Stock Purchase Agreement 08/20/12 San Diego
In Wake of Alzheimer’s Disaster, Wall Street Revisits Pfizer and J&J 08/08/12 New York
Halozyme Says Roche Work Unaffected by FDA Concerns over HyQ Program 08/06/12 San Diego
Xconomist of the Week: John Reed on Sanford-Burnham’s Drug Pipeline 08/03/12 San Diego
Enlight Bio’s Knode Advances Social Network for Pharma 08/02/12 Boston
Regulatory Concerns Over Halozyme’s Flagship Product Trigger Selloff 08/01/12 San Diego
TSI Preps for Trials of New Clot-Busting Drug 07/31/12 Boston
San Diego’s Assay Depot Unveils Online Exchange for AstraZeneca’s R&D 07/30/12 San Diego
Pet Dogs Help Biotech Startups Find New Weapons to Fight Cancer 07/25/12 San Diego
San Diego Life Sciences Roundup: Halozyme, Sophiris, Arena, & More 07/12/12 San Diego
Sophiris Moves to Unlock Blockbuster Potential in New Prostate Drug 07/10/12 San Diego
Ventrus Struggles to Reassure Street After Loss of Hemorrhoid Drug 07/03/12 New York
SD Life Sciences Roundup: Arena, PatientSafe, MEI Pharma, & More 06/28/12 San Diego
NJ Shocker: Roche to Shutter Nutley R&D Site 06/26/12 New York
Context Matters Helps Pharma Execs Make Sense of Drug Data 06/20/12 New York
Merck Sleep Drug Hits Trial Goals, Raising Hopes for New Blockbuster 06/13/12 New York
FDA Rejects Ariad/Merck Sarcoma Pill, Wall Street Unfazed 06/06/12 New York
Bayer Oncology Dubs ASCO “Turning Point” for Cancer Efforts 06/06/12 New York
Merck Oncology Chief Heads to ASCO With High Hopes for New Drugs 05/31/12 New York
Page 3 of 12 « previous page · next page »